Literature DB >> 28492850

Cancer Screening, Overdiagnosis, and Regulatory Capture.

H Gilbert Welch1.   

Abstract

Mesh:

Year:  2017        PMID: 28492850     DOI: 10.1001/jamainternmed.2017.1198

Source DB:  PubMed          Journal:  JAMA Intern Med        ISSN: 2168-6106            Impact factor:   21.873


× No keyword cloud information.
  14 in total

1.  Fear of Cancer Recurrence: A Model Examination of Physical Symptoms, Emotional Distress, and Health Behavior Change.

Authors:  Daniel L Hall; Rachel B Jimenez; Giselle K Perez; Julia Rabin; Katharine Quain; Gloria Y Yeh; Elyse R Park; Jeffrey M Peppercorn
Journal:  J Oncol Pract       Date:  2019-07-12       Impact factor: 3.840

2.  Potential Excessive Testing at Scale: Biomarkers, Genomics, and Machine Learning.

Authors:  Kenneth D Mandl; Arjun K Manrai
Journal:  JAMA       Date:  2019-02-26       Impact factor: 56.272

3.  Too Much of a Good Thing? A Cautionary Tale of Thyroid Cancer Overdiagnosis and Overtreatment.

Authors:  Maria Papaleontiou; Megan R Haymart
Journal:  Thyroid       Date:  2020-04-15       Impact factor: 6.568

4.  How Can Law and Policy Advance Quality in Genomic Analysis and Interpretation for Clinical Care?

Authors:  Barbara J Evans; Gail Javitt; Ralph Hall; Megan Robertson; Pilar Ossorio; Susan M Wolf; Thomas Morgan; Ellen Wright Clayton
Journal:  J Law Med Ethics       Date:  2020-03       Impact factor: 1.718

5.  From Overdiagnosis to Overtreatment of Low-Risk Thyroid Cancer: A Thematic Analysis of Attitudes and Beliefs of Endocrinologists, Surgeons, and Patients.

Authors:  Catherine B Jensen; Megan C Saucke; David O Francis; Corrine I Voils; Susan C Pitt
Journal:  Thyroid       Date:  2020-02-07       Impact factor: 6.568

6.  Mind-body interventions for fear of cancer recurrence: A systematic review and meta-analysis.

Authors:  Daniel L Hall; Christina M Luberto; Lisa L Philpotts; Rhayun Song; Elyse R Park; Gloria Y Yeh
Journal:  Psychooncology       Date:  2018-06-05       Impact factor: 3.894

7.  Reducing overdiagnosis in primary care is needed.

Authors:  Carl Llor
Journal:  Eur J Gen Pract       Date:  2017-12       Impact factor: 1.904

8.  Circulating long noncoding RNA act as potential novel biomarkers for diagnosis and prognosis of non-small cell lung cancer.

Authors:  Yujiao Xie; Yi Zhang; Lutao Du; Xiumei Jiang; Suzhen Yan; Weili Duan; Juan Li; Yao Zhan; Lili Wang; Shujun Zhang; Shuhai Li; Lishui Wang; Shuo Xu; Chuanxin Wang
Journal:  Mol Oncol       Date:  2018-03-25       Impact factor: 6.603

Review 9.  Potential clinical application of lncRNAs in non-small cell lung cancer.

Authors:  Tong Lu; Yuanyong Wang; Di Chen; Jia Liu; Wenjie Jiao
Journal:  Onco Targets Ther       Date:  2018-11-13       Impact factor: 4.147

10.  [Overdiagnosis in cancer].

Authors:  Mercè Marzo-Castillejo; Carmen Vela-Vallespín
Journal:  Aten Primaria       Date:  2018-09-26       Impact factor: 1.137

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.